About Fulford (India) Private Limited
Data last updated:
Fulford (India) Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Dashtag. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 02 March 1948 and has been in existence for over 78 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U99999MH1948PTC006199. Its GSTIN is 27AAACF1795L1ZA (Maharashtra). The company holds 17 GST registrations, of which 4 are active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹3.77 Cr. It was formerly known as C. E. Fulford (India) Private Limited. It is led by directors including Vikram Singh Chopra (Nodal Officer) and Subrat Kumar Ray.
Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 3012 – 3020 3rd Floor A – Wing Oberoi Garden Estate Chandivali Farm Road Andheri East, Mumbai, Maharashtra, India – 400072.
As per the financials filed for FY 2025, the company reported a revenue of ₹95.86 Cr, a growth of 50% compared to the previous year. For the same year it recorded a net profit of ₹25.44 Cr (net margin 26.5%) and EBITDA of ₹51.19 Cr (EBITDA margin 53.4%). Revenue has declined at a compounded annual rate (CAGR) of 10% over three years.
The company has about 10 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Fullford. As per MCA filings, the company has open charges of ₹15.9 Cr on record. Court records list 64 cases involving the company, including 26 filed by the company and 38 filed against it; 3 cases are pending. The company has 36 deals on record (31 market trades, 2 funding rounds, 2 acquisitions), with disclosed funding of ₹13.73 Cr; the latest was in April 2015. Its 6 peer companies in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 2 larger and 4 smaller; the largest is Medico Intercontinental Limited with revenue of ₹96.37 Cr. The company has 15 MSME Form 1 returns on record between 2019 and 2024, listing 348 overdue payments to 24 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website fulfordindia.com.
Company details
Name history
Fulford (India) has undergone 2 name changes throughout its history. The company was previously known as C. E. Fulford (India) Private Limited, and Fulford (India) Private Limited. The current legal name is Fulford (India) Private Limited.
| Company Name | Status |
|---|---|
| Fulford (India) Private Limited | Current |
| C. E. Fulford (India) Private Limited | Previous |
CIN history
Fulford (India) has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U99999MH1948PTC006199, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U99999MH1948PTC006199 | Current |
| L99999MH1948PLC006199 | Previous |
| U99999MH1948PLC006199 | Previous |
Contact details
Fulford (India) Private Limited's registered office is in Mumbai, Maharashtra.
- Registered Address3012 – 3020 3rd Floor A – Wing Oberoi Garden Estate Chandivali Farm Road Andheri East, Mumbai, Maharashtra, India – 400072
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Fulford (India) operates one associated brand: Fullford. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Human health products are developed across therapeutic areas. | fulfordindia.com |
Business activity
The main business activity of Fulford (India) is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Fulford (India) Private Limited, buy the company report.
Financials of Fulford (India) Private Limited
FY 2025 filings availableFulford (India) Private Limited reported revenue of ₹95.86 Cr (up 50% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 50% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 10%. EBITDA rose 98% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹51.19 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹25.44 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 53.4% | ||||
| Net Profit Margin | 26.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Fulford (India) Private Limited, buy the company report.
Board of directors of Fulford (India) Private Limited
Fulford (India) has 3 current directors and 40 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vikram Singh Chopra Also directs: Organon (India) Private Limited | Nodal Officer | 14 Oct 2021 | 5 Years 0 Months | Current |
| Subrat Kumar Ray Also directs: Organon (India) Private Limited | Director | 24 May 2024 | 2 Years 5 Months | Current |
| Vivek Sameer Soares Also directs: Organon (India) Private Limited | Director | 24 May 2024 | 2 Years 5 Months | Current |
Peer comparison
Fulford (India) Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medico Intercontinental Limited | ₹96.37 Cr (FY 2025) | 34.0% | Ahmedabad, Gujarat, India | |||
| Vitane Pharmaceuticals Private Limited | ₹96.05 Cr (FY 2025) | -3.0% | Thane, Maharashtra, India | |||
| Fulford (India) Private Limitedthis company | ₹95.86 Cr (FY 2025) | ₹25.44 Cr | 26.5% | 50.0% | Mumbai, Maharashtra, India | |
| Rohan Pharma Private Limited | ₹95.01 Cr (FY 2025) | 17.0% | New Delhi, Delhi, India | |||
| Paras Medical Agency Private Limited | ₹94.68 Cr (FY 2025) | 9.0% | Dombivli East, Maharashtra, India | |||
| Trishul Tradelink Private Limited | ₹94.46 Cr (FY 2017) | -3.0% | Lucknow, Uttar Pradesh, India | |||
| Ligasure Healthcare Private Limited | ₹93.82 Cr (FY 2025) | 51.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Fulford (India) Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 May 2003 | 90240989 | State Bank of India | ₹15.9 Cr | Open |
To see the full charge records of Fulford (India) Private Limited, buy the company report.
Total charge records: 1 View all charges
Deals & funding
Fulford (India) Private Limited has 36 deals on record (31 market trades, 2 funding rounds, 2 acquisitions), with disclosed funding of ₹13.73 Cr; the latest was in April 2015.
Deals on record (5 of 36)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Apr 2015 | Market trade | ₹7.25 Cr | Buyer: Vof Master Ltd. Seller: Acira Consultancy Private Limited |
| Mar 2015 | Market trade | ₹2.88 Cr | Buyer: Gandiv Investment Private Limited Seller: Gandiv Investment Private Limited |
| Mar 2015 | Market trade | ₹4.07 Cr | Seller: Gandiv Investment Private Limited |
| Dec 2014 | Market trade | ₹8.85 Cr | Buyer: Gandiv Investment Private Limited Seller: an individual |
| May 2014 | Market trade | ₹6.94 Cr | Buyer: an individual Seller: Axis Mutual Fund, Balashri Commercial Limited |
To see the full deal history of Fulford (India) Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Fulford (India) Private Limited has 64 court cases on record: 26 filed by Fulford (India), 38 filed against it. 3 cases are pending and 61 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 46 | 26 | 2 |
| District courts | 18 | 12 | 1 |
Cases on record (5 of 64)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Interim or miscellaneous application | Filed against the company by an individual | Pending |
| Bombay High Court | Tax appeal | Filed against the company by PR Commissioner of Income Tax | Pending |
| High Court of Rajasthan | Court case (CFA) | Filed by the company against M/S Suraj Medicals and 1 other | Pending |
| Bombay High Court | Interim or miscellaneous application | Filed against the company by PR Commissioner of Income Tax 2 | Disposed |
| District court, Mumbai City Civil Court, Maharashtra | Civil suit | Filed against the company by an individual | Disposed |
To see the full case history of Fulford (India) Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Fulford (India) Private Limited has 15 MSME Form 1 returns on record between 2019 and 2024, listing 348 overdue payments to 24 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 24)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Parazelsus India Private Limited | |||
| an individual supplier | |||
| DKM Online Private Limited | |||
| Suresh Surana & Associates LLP | |||
| Iris Regtech Solutions Limited |
To see the full MSME payment records of Fulford (India) Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Fulford (India) has 17 GST registrations: 4 active and 13 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACF1795L1ZA | Maharashtra | Active | 01 Jul 2017 |
| 27AAACF1795L2Z9 | Maharashtra | Active | 27 Jul 2017 |
| 19AAACF1795L1Z7 | West Bengal | Active | 01 Jul 2017 |
| 36AAACF1795L1ZB | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Fulford (India) Private Limited, buy the company report.
Recent activity
Fulford (India) Private Limited has 43 board changes on record since 2007: 3 appointments and 40 cessations. The latest: Subrat Kumar Ray ceased to be Additional Director on 16 Sep 2024.
36 earlier events are in the company report.
Frequently asked questions
Fulford (India) is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 02 March 1948 (78+ years old) and is registered under CIN U99999MH1948PTC006199.
Fulford (India) has 3 current directors:
- Subrat Kumar Ray - Director
- Vivek Sameer Soares - Director
- Vikram Singh Chopra - Nodal Officer
The latest financial statements of Fulford (India) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 26 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Fulford (India) is 27AAACF1795L1ZA, registered in Maharashtra. The company has 17 GST registrations in all, of which 4 are active and 13 are cancelled or inactive. Other active GSTINs include 27AAACF1795L2Z9 (Maharashtra), 19AAACF1795L1Z7 (West Bengal), 36AAACF1795L1ZB (Telangana).
The CIN (Corporate Identification Number) of Fulford (India) is U99999MH1948PTC006199. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Fulford (India) has 64 court cases on record: 26 filed by the company and 38 filed against it. 3 are pending. Most are in the high courts.
Fulford (India) was incorporated on 02 March 1948, making it 78+ years old. It is registered with the Registrar of Companies, Mumbai.
Fulford (India) has 36 deals on record (31 market trades, 2 funding rounds, 2 acquisitions), with disclosed funding of ₹13.73 Cr; the latest was in April 2015.
The peers of Fulford (India) by revenue are Medico Intercontinental Limited, Vitane Pharmaceuticals Private Limited, Rohan Pharma Private Limited, Paras Medical Agency Private Limited, Trishul Tradelink Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Subrat Kumar Ray ceased to be Additional Director on 16 Sep 2024. Vivek Sameer Soares ceased to be Additional Director on 16 Sep 2024. Subrat Kumar Ray was appointed as Director on 24 May 2024. Fulford (India) has 43 board changes on record in total.
Fulford (India) has 15 MSME Form 1 returns on record between 2019 and 2024, listing 348 overdue payments to 24 micro and small suppliers. The latest return was filed on 29 Apr 2024.
Fulford (India) can be reached through the website fulfordindia.com. Its registered office is in Mumbai, Maharashtra, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
